Autorisation d’accès précoce refusée à la spécialité EMCITATE (tiratricol) dans l'indication « traitement de la thyrotoxicose périphérique chez les patients atteints d’un déficit en transporteur 8 de monocarboxylate (MCT8) (syndrome d’Allan-Herndon-Dudley), dès la naissance. »
See also
HAS opinions and decisions
07/08/2025
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
4ZfYfkSgKPfxUhq1
